1291782

Renata Stawerska, MD, PhD — FEI 3039046172

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 24, 2025
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Lodz (Poland)

Additional Details

Clinical Investigator (CI)